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Haiping Fang 
Despite long-term efforts for exploring antibacterial agents or drugs, it remains challenging how to potentiate 
antibacterial activity and meanwhile minimize toxicity hazards to the environment. Here, we experimentally show 
that the functionality of reduced graphene oxide (rGO) through copper ions displays selective antibacterial 
activity significantly stronger than that of rGO itself and no toxicity to mammalian cells. Remarkably, this 
antibacterial activity is two orders of magnitude greater than the activity of its surrounding copper ions. We 
demonstrate that the rGO is functionalized through the cation–π interaction to massively adsorb copper ions to 
form a rGO–copper composite in solution and result in an extremely low concentration level of surrounding 
copper ions (less than ~0.5 µM). These copper ions on rGO are positively charged and strongly interact with 
negatively charged bacterial cells to selectively achieve antibacterial activity, while rGO exhibits the functionality 
to not only actuate rapid delivery of copper ions and massive assembly onto bacterial cells but also result in the 
valence shift in the copper ions from Cu2+ into Cu+ which greatly enhances the antibacterial activity. Notably, this 
functionality of rGO through cation–π interaction with copper ions can similarly achieve algaecidal activity but 
does not exert cytotoxicity against neutrally charged mammalian cells. The remarkable selective antibacterial 
activity from the rGO functionality as well as the inherent broad-spectrum-antibacterial physical mechanism 
represents a significant step toward the development of a novel antibacterial material and reagent without 
environmental hazards for practical application.  
 
Prof. Y. Tu, J. Sun, Dr. Y. Wu  
College of Physics Science and Technology, Yangzhou University  
Jiangsu, 225009, China 
E-mail: ystu@yzu.edu.cn; jjsun_yzu@163.com; yywu@yzu.edu.cn 
Prof. Y. Tu 
Key Laboratory of Polar Materials and Devices Ministry of Education, School of Physics and Electrical Science 
East China Normal University, Shanghai 200241, China 
E-mail: ystu@clpm.ecnu.edu.cn 
P. Li, Prof. Y. Tan 
State Key Laboratory of Surface Physics, Multiscale Research Institute of Complex Systems 
Department of Physics, Fudan University Shanghai 200433, China 
E-mail: peili92@alu.fudan.edu.cn; ywtan@fudan.edu.cn 
J. Jiang, Prof. H. Fang 
Division of Interfacial Water and Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied 
Physics, Chinese Academy of Sciences, Shanghai 201800, China 
E-mail: jiangjie@sinap.ac.cn; fanghaiping@sinap.ac.cn 
F. Dai, Prof. L. Chen 
Department of Optical Engineering, Zhejiang A&F University, Lin'an 311300, China 
E-mail: fangfangdai94@126.com; liang_chen05@126.com 
Prof. G. Shi 
Shanghai Applied Radiation Institute, Shanghai University, Shanghai 200444, China 
E-mail: gsshi@shu.edu.cn 
Prof. H. Fang 
School of Science, East China University of Science and Technology, Shanghai 200237, China 
†These authors contributed equally to this work. 
Page 2 of 16 
1. Introduction 
How to selectively potentiate antibacterial activity and 
meanwhile minimize toxicity hazards to the environment 
is a major and vital question for improving human and 
animal health and agricultural yields [1]. Antibacterial 
drugs or antibiotics were introduced more than 70 years 
ago, however, their widespread uses in healthcare and 
agriculture have resulted in the accumulation of 
antibiotics in the environment [2]. This has become an 
increasingly common health threat due to the emergence 
and spread of bacterial resistance in the environment [3]. 
Also, copper antibacterial activity was recognized in 
ancient times, and its ions and complexes have been 
shown to possess broad-spectrum antimicrobial [4], 
antifungal and antiviral activity [5]. However, in excess, 
copper ions become toxic and adversely pose hazards to 
the environment, especially to the aquatic environment [6]. 
Despite long-term efforts on counteracting the increasing 
resistance of bacteria by decreasing the inappropriate use 
of antibiotics as well as researching and developing new 
antibacterial materials or agents [7], there is an urgent 
need yet a challenge for achieving the selective, 
highly-efficient, and environmentally-friendly 
antibacterial activity. 
 
Graphene is a 2D single-atom-thick nanomaterial with 
hexagonally-assigned sp2-bonded carbon [8], and its 
unique structure can result in excellent physicochemical 
properties for various applications [9]. Previous researches 
have shown that graphene can present antibacterial 
activity [10], and the activity mainly originate from its 
characteristic interactions with bacterial cells, i.e., cutting 
membranes or extracting large amounts of phospholipids 
from membranes or covering onto membranes [10a, 10b], in 
comparison with the translocating or penetrating 
membranes of other 0D or 1D nanomaterials [11]. Many 
efforts have also been made to study the antibacterial 
activity of functionalized graphene, but the enhancement 
of this activity was found to be less than twofold in 
comparison with graphene [12]. For example, graphene 
functionalized by conjugating polymers [12a] and with 
controlled orientational alignment [12b] had antibacterial 
activity enhanced by only 1.30- and 1.46-fold, 
respectively. 
 
Here, we experimentally report an unexpectedly 
amplified selective antibacterial activity of reduced 
graphene oxide (rGO) functionalized by only copper ions, 
without toxicity to mammalian cells. The antibacterial 
activity is significantly stronger than that of rGO itself 
and two orders of magnitude greater than that of the 
surrounding copper ions. We have performed density 
functional theory (DFT) calculations and molecular 
dynamics (MD) simulations showing that rGO is 
functionalized through cation–π interaction to massively 
adsorb copper ions to form a rGO–copper composite and 
result in an extremely low concentration level of 
surrounding copper ions (less than ~0.5 µM). These 
copper ions on rGO are positively charged and strongly 
interact with negatively charged bacterial cells to 
selectively achieve antibacterial activity. Importantly, 
along with our field-emission scanning electron 
microscopy (FE-SEM) and X-ray photoelectron 
spectrometer spectra (XPS) experiments, these results 
reveal the inherent broad-spectrum-antibacterial physical 
mechanism on the functionality of rGO through cation-π 
interaction with copper ions, i.e., the rGO functionality 
not only actuates rapid delivery of copper ions and 
massive assembly onto bacterial cells but also results in 
the valence shift in the copper ions from Cu2+ into Cu+, 
which greatly enhances the antibacterial activity. Notably, 
this functionality of rGO through copper ions can 
similarly achieve algaecidal activity but does not exert 
cytotoxicity against neutrally charged mammalian cells. 
Our results indicate that this rGO functionality has taken 
the most advantage of the charge difference between the 
cells to achieve the remarkable selective antibacterial 
activity and meanwhile avoiding environmental hazards. 
 
2. Results and discussions 
2.1 Antibacterial Activities from rGO Functionality 
through Copper Ions.  
We prepared rGO suspensions from natural graphite 
powder by using a modified Hummers method and 
electron-beam irradiation reduction (see the Experimental 
Section for details). The as-prepared rGO was mainly a 
single-layer sheet with average lateral dimension of ~10 
µm (Supporting Information, Figure S2). We added a small 
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Figure 1. Remarkable antibacterial activity of rGO functionalized by copper ions. (A) Images of colony-forming cell 
assays against E. coli (upper row) and S. aureus (following row). Bacterial cells were incubated with deionized water as 
the control, with rGO solution (40 µg mL−1), with rGO–copper composite solution (40 µg mL−1 rGO and 100 µM copper 
sulphate [CuSO4]), and with CuSO4 solution (3 µM). The CuSO4 solution (3 µM) was employed as a reference for the 
surrounding copper ion concentration in the rGO–copper composite solution (determined to be less than ~0.5 µM; 
Supporting Information, Figure S1). (B) Antibacterial activity (left axis) against E. coli (upper) and S. aureus (down), 
represented by the ratio of the colony number in the control experiment to the colony numbers in antibacterial 
experiments, and enhancement ratio (right axis) of rGO–copper antibacterial activity relative to the antibacterial activity 
of the surrounding copper ions (3 µM). The error bars indicate standard deviations in experiments with three samples. (C) 
FE-SEM morphology images and elemental mappings of carbon and copper for the rGO–copper-incubated and 
CuSO4-incubated E. coli cells. The yellow arrows indicate the regions marked by E. coli (EX), E. coli (EY), nearby (N), 
E. coli (E), and background (B), from which data were collected to quantify the Cu content. (D) Increments of Cu 
content (left axis) on the rGO–copper-incubated cells (EX and EY) and CuSO4-incubated cells (E) over the background 
Cu content (B) as well as the ratio (right axis) of the Cu increment on the cells (EX and EY) to the increment on the cell 
(E). The average Cu content and errors were evaluated using energy-dispersive X-ray spectroscopy (EDS) measurement 
performed at five random loci around the arrow-indicated regions in A (Supporting Information, Figure S3). 
amount of the rGO suspension to copper sulphate (CuSO4) 
solution to form a rGO–copper composite solution. We 
used a conventional colony-forming cell assay to analyze 
antibacterial activity against Gram-negative Escherichia 
coli (E. coli) and Gram-positive Staphylococcus aureus (S. 
aureus). As illustrated in Figure 1A, after incubation with 
the rGO–copper composite solution (40 µg mL−1 rGO and 
100 µM CuSO4), bacterial cells are present in only three 
and eight colonies for E. coli and S. aureus respectively, 
demonstrating remarkable antibacterial activity. By 
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contrast, after incubation with rGO itself (40 µg mL−1), 
bacterial cells are present in dense colonies similar to 
those in the control experiment, indicating that the rGO 
hardly provides antibacterial activity. This is consistent 
with previous experimental results obtained for GO with 
similar lateral dimensions of 5–20 µm and at 
concentrations lower than 103 µg mL−1 [13]. Thus, the 
rGO–copper composite solution has significantly stronger 
antibacterial activity than the rGO solution itself. To 
confirm that this enhanced antibacterial activity results 
essentially from the rGO–copper composite, we 
investigated the antibacterial activity of surrounding 
copper ions in the composite solution. Accordingly, the 
rGO–copper composite was filtered and removed, and the 
copper ions in the residual solution were measured and 
presumed to be the surrounding copper ions in the 
composite solution. Notably, the concentration level of 
surrounding copper ions is extremely low (lower than 
~0.5 µM, detected with inductively coupled plasma 
optical emission spectrometer (ICP-OES); Supporting 
Information, Figure S1), which is at the same order of 
magnitude of water quality criteria [14]. This indicates the 
functionality of rGO to strongly adsorb copper ions to 
form a rGO–copper composite. Furthermore, because 0.5 
µM is too low a concentration for accurate quantification 
of antibacterial activity, we postulated approximately 3 
µM to be the reference concentration of the surrounding 
copper ions. For this concentration, the colonies of 
CuSO4-incubated bacterial cells are slightly sparser than 
those in the control experiment, indicating weak 
antibacterial activity (Figure 1A). By comparison, the 
rGO–copper composite exhibits antibacterial activity at 
least 220 times higher than that of the surrounding copper 
ions in the solution (Figure 1B upper). Similarly, results 
demonstrated that this functionality of rGO through 
copper ions likewise displays significant antibacterial 
activity against S. aureus ant this activity is ~27 times 
higher than that of the surrounding copper ions in the 
solution (Figure 1B down). (Supporting Information, 
Figure S4 for all three parallel antibacterial experiments). 
 
2.2 Elemental Cooper Mapping by FE-SEM.  
We adopted FE-SEM to test whether this antibacterial 
activity originates from the functionality of rGO to 
adsorb copper ions and even deliver them onto bacterial 
cells. The elemental carbon mappings presented in Figure 
1C are consistent with the morphologies of the 
corresponding bacterial cells, mainly because of the high 
C content of the cells. In particular, the rGO is depicted to 
cover and even wrap the rGO–copper-incubated cells in 
the morphology image, and these profiles are also 
consistent with the C mappings. In contrast, the elemental 
copper mapping of the rGO–copper-incubated cells has a 
consistent profile with the morphologies of cells covered 
and wrapped by rGO. The signal intensity for Cu is even 
comparable to the signal intensity for C from the bacterial 
cells. However, only background noise signals for Cu are 
present on the mappings of the CuSO4-incubated cells at 
the corresponding copper ion concentration. Figure 1D 
illustrates that the increments of the Cu contents on the 
rGO–copper-incubated cells over the background Cu 
content are approximately 20-fold larger than the 
increments on the CuSO4-incubated cells. These results 
clearly demonstrate the functionality that the rGO 
massively adsorbs copper ions and further delivers and 
assembles copper ions onto bacterial cells to greatly 
enhance the antibacterial activity. 
 
2.3 Antibacterial Activities from the Functionality of 
Graphene Oxide Quantum Dots (GOdot) through 
Copper Ions.  
We examined the functionality of GOdot (around ten 
nanometers, confirmed by AFM, Supporting Information, 
Figure S2) for antibacterial activity. A small amount of 
GOdot suspension were added to CuSO4 solution to form 
a GOdot–copper composite solution, and the antibacterial 
experiments were performed under the same 
concentration conditions as rGO–copper composite (40 
µg mL−1 GOdot and 100 µM CuSO4). As shown in 
Figure 2A and 2B, despite different lateral sizes, the 
GOdot presents consistent functionality with rGO, through 
copper ions to achieve remarkable antibacterial activity. 
Nevertheless, in contrast to rGO, the GOdot–copper 
composite exhibits significantly stronger antibacterial 
activities, and the enhancement ratios of the 
GOdot–copper antibacterial activity are even up to 
~1´106 and ~5´103 times, respectively against E. coli and 
S. aureus. 
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Figure 2. (A) and (B) Antibacterial activities (left axis) of GOdot functionalized by copper ions and enhancement ratios 
(right axis) of GOdot–copper antibacterial activity relative to the antibacterial activity of the surrounding copper ions (3 
µM), against E. coli (A) and S. aureus (B). The concentration conditions are the same as in Figure 1, besides 40 µg mL−1 
GOdot. The CuSO4 solution (3 µM) was also postulated as a reference for the surrounding copper ion concentration in 
the GOdot–copper composite solution. (C) and (D) Tendencies of the antibacterial activities and the enhancement ratios 
against E. coli with respect to copper ion concentrations (100 µM, 50 µM, 25 µM, 10 µM). The error bars indicate 
standard deviations in experiments with three samples. 
Unexpectedly, the GOdot functionality through copper 
ions exhibits at least more than two orders of magnitudes 
larger enhancement ratios of antibacterial activities than 
the rGO functionality. We attribute this effect to the 
drastically increased number concentration of GOdot 
under the same mass concentration with rGO sheets. 
From a simple estimation (Supporting Information, PS3), 
one large rGO sheet (~10 µm) corresponds to 106 
nanosheets of Godot (~10 nm) under the same mass 
condition, i.e., compared with the rGO, the GOdot can 
have around 106 times higher probability to interact with 
bacterial cells under the same mass concentration and 
consequently brings about the unexpected enhancement 
ratios of the antibacterial activity. This indicates that the 
lateral sizes have no essential influence on the rGO 
functionality and small lateral sizes may provide the 
significant advantage for further boosting up its 
enhancement ratios of antibacterial activities. 
Furthermore, we performed antibacterial experiments 
under various copper ion concentrations. Figure 2C and 
2D shows the antibacterial activity against E. coli from 
rGO and GOdot functionality with respect to the CuSO4 
concentrations as well as the relevant enhancement ratios. 
While the enhancement ratios present a decrease 
tendency as the ion concentrations are reduced, the rGO 
functionality through copper ions under 10 µM still 
presents the enhancement ratio of 13 times, and the 
GOdot functionality through copper ions under 25µM 
displays the enhancement ratio of larger than 105 times. 
This confirms the validity of the functionality to achieve 
the remarkable antibacterial activity even under the very 
low concentration of copper ions. 
 
2.4 Characterization of rGO–copper Composite and 
Molecular Mechanism Analysis.  
We used XPS to characterize the rGO–copper composite 
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as well as to measure CuSO4, Cu2SO4, and rGO only as 
the references. Figure 3A shows their Cu 2p3/2 XPS 
spectra. The CuSO4 presents a Cu2+ characteristic peak at 
~935.0 eV, consistent with the previous XPS spectra of 
CuSO4 [15]; the Cu2SO4 presents a Cu+ characteristic peak 
at ~932.6 eV, consistent with previous XPS spectra of 
Cu2O or Cu2S in the NIST XPS Database despite no data 
of Cu2SO4 in the Database [15]. The rGO does not include 
any copper element and thus presents only flat noise 
signals. Notably, in contrast, all three samples of 
rGO–copper composite display the broad overlapping 
peaks, clearly indicating the Cu+ characteristic peaks near 
~932.6 eV besides Cu2+ characteristic peaks at ~935.0 eV. 
This indicates that the copper ions in CuSO4 solution 
present the valence shift from +2 to +1 after being 
adsorbed on rGO to form rGO–copper composite.
 
Figure 3. Adsorption interaction between rGO and copper ions as well as the rGO–copper composite. (A) Cu 2p3/2 X-ray 
photoelectron spectrometer spectra (XPS) of three samples of rGO–copper composite as well as CuSO4, Cu2SO4, and rGO 
only. The grey and red dashed lines mark peaks at ~935.0 eV and ~932.6 eV corresponding to the Cu2+ and Cu+ 
characteristics, respectively. (B) The optimized geometries (upper) of copper ion with the valence of +2 on both graphene 
and GO sheets corresponding to the unoxidized and oxidized regions of rGO, respectively, as well as the relevant Mulliken 
charge distributions (middle) and highest occupied molecular orbitals (HOMO) (down). ∆E = ErGO–copper – Ecopper – ErGO, 
where ∆E is the binding energy of copper ion adsorption onto rGO, ErGO–copper, Ecopper and ErGO are the total energies of 
optimized rGO–copper composite, copper ion and rGO, respectively. The rGO is shown as bonded spheres (C: yellow, O: 
red, and H: white) and copper ion, as a green sphere. The red and blue represent the negative and positive charged atoms. 
The electron density was plotted for iso values of 0.005 a.u. with the red and blue colors denoting the opposite signs.
DFT calculations were performed to understand the 
adsorption interaction between rGO and copper ions in 
rGO–copper composite at the B3LYP/6-31G(d) level of 
theory. [16] We have optimized the structures of copper ion 
adsorption on rGO with zero, one, two, three and four 
oxygen functional groups, mainly considering the 
influence from oxygen functional groups at the first 
neighbor sites around the adsorption sites on rGO for 
simplification (Supporting Information, Figure S5). 
Figure 3B shows the representative optimized geometries 
of copper ion adsorption on both graphene and GO sheets 
that correspond to the unoxidized and oxidized regions of 
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rGO respectively, as well as the relevant Mulliken charge 
distributions and highest occupied states of the molecular 
orbitals (HOMO) (see all optimized structures in Figure 
S5 in Supporting Information). We find that the binding 
energies of copper ion adsorption on rGO are all two 
orders of magnitude larger than the hydrogen binding 
energy in liquid water, indicating the strong adsorption of 
copper ions on rGO that is consistent with our detections 
in ICP-OES experiment (Supporting Information, Figure 
S1). Further, the HOMO represent all of the molecular 
orbitals with the cation-π interactions between the copper 
ion and rGO surfaces and clearly display the strong 
couplings between the orbitals of the copper ions and the 
delocalized π states of the aromatic-ring structures in rGO 
surfaces. [9a, 17]Mulliken charge distributions show that the 
copper ions adsorbed on rGO remain partial charges of 
around +0.5 in comparison with its original valence of +2, 
representing the significant charge transfers between the 
unoccupied valence orbitals of copper ion and the 
delocalized π states of the aromatic ring structure in the 
rGO. This demonstrates that the empty valence orbitals of 
the copper ion have a strong electron-withdrawing 
capability and accepted partial electrons from the 
delocalized π orbitals of the aromatic-ring structure of 
rGO during the adsorption process, consistent with our 
XPS experiments on the valence shift of copper ions from 
+2 to +1 after being adsorbed on rGO. All these results as 
well as the XPS experiments have demonstrated the 
strong cation–π interaction between copper ions and the 
aromatic rings of rGO such that copper ions can be 
adsorbed on rGO very stably. 
 
Further, we performed MD simulation to analyze the 
interactions of the rGO–copper composite and the rGO 
with the bacterial cell membrane. [10a, 18] Herein, based on 
the cation-π interaction, we randomly selected sites on 
rGO and constrained copper ions onto rGO to form a 
rGO–copper composite (Supporting Information, Figure 
S6); meanwhile, bacterial cell membranes were simulated 
with a mixture of neutral 
palmitoyloleoylphosphatidylethanolamine (POPE) and 
negatively charged palmitoyloleoylphosphatidylglycerol 
(POPG) at a 3:1 ratio in explicit solvent environment ,[10a] 
since negatively charged membranes usually occur with 
bacterial cells. [19] 
 
Two representative MD trajectories of the rGO–copper 
composite and rGO interacting with bacterial cell 
membranes were shown in Figure 4A and Figure 4B, 
respectively. The rGO–copper composite is rapidly 
adsorbed and comes into contact with the membrane 
within 15 ns. By contrast, the rGO first moves around for 
~115 ns; subsequently, after one of its corners becomes 
close to the membrane at ~115 ns, it takes an additional 
~30 ns to come into complete contact with the membrane. 
The rGO–copper composite reaches the membrane much 
more rapidly than does rGO. Figure 4C further illustrates 
the movement of the centers of mass of the rGO–copper 
composite and rGO toward the membrane and presents 
their interaction energy profiles. As they approach the 
membranes, the rGO–copper composite exhibits a much 
more rapid increase in interaction energy with the cell 
membrane than does rGO, and its final energy is more 
than three times higher than that of rGO. This much 
higher energy essentially results from the electrostatic 
interaction between the copper ions of the rGO–copper 
composite and the negatively charged membrane. 
Therefore, rGO is functionalized to massively adsorb 
copper ions to form the rGO–copper composite through 
the cation–π interaction between copper ions and 
π-electrons in the aromatic rings of rGO. [9a, 17a] These 
copper ions on rGO are positively charged and strongly 
interact with negatively charged bacterial cells to achieve 
antibacterial activity, while rGO exhibits the functionality 
to actuate rapid delivery of copper ions and assembly 
onto bacterial cells to greatly enhance the antibacterial 
activity, which was consistent with our FE-SEM 
observations above (Figure 1C and 1D). 
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Figure 4. Molecular interaction of the functionalized rGO–copper composite with bacterial cell membranes. (A) and (B) 
Representative MD trajectories of the interactions between cell membranes (3:1 mixed POPE and POPG, negatively 
charged) and rGO–copper composite (A) and rGO (B). The snapshot times are displayed in the top left corners. Water is 
shown as ice blue lines, phospholipids as tan lines, and hydrophilic charged atoms as colored spheres (H: white, O: red, 
N: dark blue, C: cyan, and P: orange). The rGO is shown as bonded spheres with oxidized groups (C: yellow, O: red, and 
H: white). The copper ions of the rGO–copper composite are displayed as large green spheres. (C) Time evolution of the 
interaction energy between cell membranes and the rGO–copper composite and rGO (red and orange curves, respectively, 
right axis), and center-of-mass distances of the rGO–copper composite and rGO along the z-direction toward cell 
membranes (black and gray curves, respectively, left axis). The blue dashed lines indicate 15 and 145 ns, corresponding 
to the time at which the rGO–copper composite and rGO reached the membrane surface, respectively. 
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Figure 5. Algaecidal activity of the functionalized rGO–copper composite and its cytotoxicity against a mammalian cell. 
(A) Images of fluorescence-viable cells in experimental FDA assay of algaecidal activity of the rGO–copper composite 
against C. reinhardtii. (B) Algaecidal activity (left axis) of rGO–copper composite, and enhancement ratio relative to the 
surrounding copper ions (right axis). The error bars indicate standard deviations in 30 parallel experiments. (C) and (D) 
Cytotoxicity of rGO–copper (C) and GOdot–copper (D) composite against a mammalian cell (human embryonic kidney 
293T), and enhancement ratios relative to the surrounding copper ions. The blue dashed line marks the level of no 
cytotoxicity. The error bars indicate standard deviations in three parallel experiments. The algae and mammalian cells 
were incubated with the same corresponding copper ion and/or rGO concentrations as in Figure 1A. The definitions of 
algaecidal activity and cytotoxicity and their relevant enhancement ratios are the same as those in Figure 1B. 
 
2.5 Algaecidal Activities and Mammalian Cytotoxicity 
of rGO–copper Composite.  
In addition to bactericidal activity, we verified the 
algaecidal activity of the rGO–copper composite. In 
fluorescein diacetate (FDA) assay, rGO-incubated algae 
(Chlamydomonas reinhardtii) cells are present as dense 
FDA-dyed viable cells similar to those observed in the 
control experiment (Figure 5A), indicating that rGO 
hardly present algaecidal activity. By contrast, after 
incubation with the rGO–copper composite, only one 
FDA-dyed viable cell is observed, indicating that the 
algaecidal activity of the composite is much stronger than 
that of rGO itself. The algaecidal activity of the 
rGO–copper composite is approximately 26 times that of 
the surrounding copper ions (Figure 5B). 
 
For biomedical applications, examining the cytotoxicity 
of the rGO–copper composite against mammalian cells is 
critical. As shown in Figure 5C and 5D, all the rGO, 
rGO–copper, GOdot, and GOdot-copper composites have 
no cytotoxicity against a mammalian cell (human 
embryonic kidney 293T) (Supporting Information, Table 
1). The rGO–copper and GOdot–copper composites 
present almost the same cytotoxicity (only ~1.2 times 
stronger) as the surrounding copper ions, indicating no 
enhancement effect from the functionality of rGO and 
GOdot through copper ions. Previous cytotoxicity tests 
showed that only high copper ion concentrations (>103 
µM) could damage mammalian cells. [20] In this study, 
despite the high local copper ion concentration on the 
rGO–copper composite due to the strong adsorption of 
copper ions by rGO, mammalian cells are usually 
neutrally charged [21] so that the copper ions of the 
rGO–copper composite are not preferentially delivered 
and assembled onto the mammalian cells; thus, the 
cytotoxicity is not enhanced. By contrast, algae cells 
usually have negatively charged membranes, similar to 
bacterial cells; [22] the algaecidal activity of the composite 
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is explained by the same interaction mechanism as that 
for antibacterial activity. 
 
3. Conclusions 
 
In summary, we have demonstrated the remarkable 
selective antibacterial activity of the rGO functionalized 
by copper ions and no toxicity to mammalian cells. 
Through the functionality of rGO, the concentration of 
surrounding copper ions in solution is maintained at the 
extremely low level (less than approximately 0.5 µM, 
Supporting Information, Figure S1), which is at the same 
order of magnitude of water quality criteria. [14] More 
excitingly, the consequent rGO–copper composite 
exhibits antibacterial activity two orders of magnitude 
higher than that of its surrounding copper ions. Notably, 
this functionality of rGO through copper ions is also 
validated to similarly achieve algaecidal activity. In 
contrast with copper ions, we have also attempted to 
functionalize rGO by zinc and nickel ions but found no 
enhancement of antibacterial activity from the consequent 
rGO–zinc and GOdot–nickel composites (Supporting 
Information, Figure S8). 
 
In order to reveal the mechanism of this remarkable 
antibacterial activity, element copper mapping by 
FE-SEM has been employed. Cu contents on 
rGO–copper-incubated cells are approximately 20-fold 
larger than the increments on the CuSO4-incubated cells, 
demonstrating that the rGO may prefer to massively 
deliver and assemble the adsorbed copper ions onto 
bacterial cells to enhance the antibacterial activity. 
Meanwhile, our DFT calculations indicate that this 
functionality of rGO originates from the strong cation-π 
interaction between copper ions and the aromatic rings of 
rGO (Supporting Information, Figure 3B and Figure S5). 
Nearly all bacterial cells found in nature are negatively 
charged [19] (Supporting Information, PS8), while the rGO 
are positively charged by copper ions through their 
cation–π interaction. Whether the oppositely electrical 
properties will enhance the interaction between 
rGO–copper composites and cell membranes has been 
explored by our MD simulations (Figure 4C and 
Supporting Information, Figure S7). The more rapidly 
contacting of rGO–copper composite to cell membranes 
as well as the much stronger interacting energy with the 
membrane in comparison with rGO only have confirmed 
our suspicions on the great enhancement on the 
interaction between positively charged rGO and 
negatively charged cell membranes. On the other hand, 
our XPS experiments and DFT calculations has further 
demonstrated that, in rGO-copper composite the rGO 
induces a valence shift of copper ions from +2 to +1, 
besides the strong adsorptions of copper ions (Figure 3 
and Supporting Information, Figure S5). Notably, while 
the precise mechanism remains unclear, for more than 40 
years it has been recognized Cu+ ions are considerably 
more toxic to bacteria than Cu2+ ions under test 
conditions where the enhancements of Cu2+ cytotoxicity 
are mainly attributed to the reduction of copper that 
results in a shift in total copper from the Cu2+ to the Cu+ 
oxidation state. [23] Therefore, all these results reveal the 
inherent physical mechanism on the functionality of rGO 
through cation-π interaction with copper ions that not 
only actuates rapid delivery of copper ions and massive 
assembly onto bacterial cells but also results in the 
valence shift in the copper ions from Cu2+ into Cu+ , 
which greatly enhances the antibacterial activity. In 
contrast, similar cytotoxicity test to HEK 293T cells has 
been accomplished by MTT assay, and both rGO only 
and the rGO functionalized through copper ions showed 
no cytotoxicity against mammalian cells. 
 
It is worth noting that the GOdot, as smallest-lateral size 
GO, has also been demonstrated to have consistent 
functionality with the rGO to selectively achieve 
remarkable antibacterial activity yet exert no toxicity to 
mammalian cells. Our analysis supports that the lateral 
sizes have no essential influence on the rGO functionality. 
Meanwhile, the small lateral sizes of GOdot bring about 
the significant advantage on the high-probability 
interactions with bacterial cells to further boost up the 
antibacterial activity, since the number concentration of 
GOdot is drastically increased at the same mass 
concentrations as rGO. Nevertheless, despite the 
significant advantage, since it is rather hard to remove 
nanosized GOdot by the centrifugation or filtering, we 
may also have to reappraise and confront the 
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environmental hazards of nanosized GOdot in practical 
use that is similar to the hazards from copper ions, and the 
choice of specific sized GO should be determined with 
specific application scenarios. 
 
Herein, this functionality of rGO through cation–π 
interaction with copper ions was first revealed in our 
computations, and then was validated with our ICP-OES 
detections, FE-SEM observations, and XPS 
measurements. We attribute the selective cytotoxicity 
against both bacteria and algae cells to this functionality 
of rGO, and these copper ions on rGO are positively 
charged and selectively and strongly interact with both 
negatively charged cells rather than with neutrally 
charged mammalian cells. We note that pathological cells 
(e.g., cancer cells) likewise carry a net negative charge [24] 
and several cationic antimicrobial peptides were reported 
to display the advantage of their electrostatic interactions 
for cancer cell-selective toxicity. [25] The rGO 
functionality exhibited here takes the most advantage of 
the charge difference between the cells to achieve the 
remarkable selective antibacterial activity and meanwhile 
avoid environmental hazards, which offers guidance on 
the design for highly effective and selective anticancer 
activity. Considering the scalable production and the easy 
removal of rGO through centrifugation or filtering, the 
antibacterial and algaecidal activities from the 
functionality of rGO through copper ions as well as the 
inherent broad-spectrum-antibacterial physical mechanism 
represent a large step toward achieving a cheap, facile, 
highly efficient, broad-spectrum, and environmentally 
friendly antibacterial material and reagent for practical 
application.
 
4. Experimental Section 
Fabrication of reduced graphene oxide suspensions: Graphene oxide (GO) suspension were prepared from natural 
graphite powder via a modified Hummers method [9a, 26]. Graphite powders were pre-oxidized by concentrated H2SO4, 
K2S2O8, and P2O5 solution with continuous stirring for several hours. Then, we diluted the mixture with deionized water, 
centrifuged at 10,000 rpm, and washed with deionized water; after drying process, we obtained the pre-oxidized graphite. 
Further oxidization treatments were performed in concentrated H2SO4 and KMnO4, diluted with deionized water, 
followed by the addition of 30% H2O2. In order to remove ion species, the product was centrifuged and washed 
sequentially with 1:10 HCl aqueous solution and deionized water. Eventually, by centrifugation at 4000 rpm, few-layer 
graphene oxide was separated to obtain GO suspension. 
 
Electron-beam irradiation (EBI) reduction method is essentially radiation water production hydrated electrons as a 
medium involved in chemical reactions [27]. Hydrated electrons chemically react with the oxygen-containing groups on 
GO surfaces to reduce the oxygen content to achieve reduced GO (rGO) [28]. The GO suspension and isopropanol were 
mixed at a volume ratio of 3:2. The mixed solutions were put into a sealed bag filled with nitrogen gas and irradiated 
with a dose of 5 kGy under room temperature. The electron accelerator has a beam intensity of 5 mA and an energy of 
1.8 MeV. Finally, the rGO solution was washed sequentially with deionized water by centrifugation. 
 
Purchase of graphene oxide quantum dots suspensions: The GOdot suspensions (XF091, ~10 nm) were purchased from 
Nanjing XFNANO Materials Tech Co. Ltd. 
 
Atomic force microscopy (AFM) measurements: AFM measurements were performed on Multimode V atomic force 
microscope, in tapping mode. The tips used have resonance of approximately 300 kHz. The samples for the AFM 
imaging were prepared by drop-casting a diluted suspension (0.03 mg/mL) onto a cleaned mica substrate and dried at 
room temperature. 
 
XPS measurements: XPS was used to characterize the rGO–copper composite. The XPS measurements were performed 
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with a ThermoFisher ESCALAB 250Xi spectrometer, using a monochromatic Al K Alpha (1486.6 eV) X-ray source (6 
mA, 12 kV). We drop-casted the droplets of rGO suspension onto a smooth paper substrate to produce freestanding rGO 
membranes. These freestanding rGO membranes were dried at 70 ºC for 12 hours. Then, they were peeled off and 
immersed in CuSO4 solution with a concentration of 1.05 M at room temperature for 2 hours. At last, the wet membranes 
with salt solution were taken out, remove the free solution by absorbent paper and dried again at 70ºC for 12 hours. The 
consequent dried membranes of rGO–copper composite were characterized by XPS. Meanwhile, pure rGO membrane, 
CuSO4 and Cu2SO4 were also measured by XPS as the references for the membranes of rGO–copper composite. The 
anhydrous cupric sulfate (CuSO4, 99%) powders were purchased from Shanghai Aladdin Bio-Chem Technology Co., Ltd. 
The anhydrous cuprous sulfate (Cu2SO4) powders were prepared with cuprous oxide (Cu2O) and dimethyl sulphate 
(C2H6SO4). Herein, 14.3g Cu2O powders and 10 ml C2H6SO4 were added into a beaker, which were sealed with a PE 
film. The mixture was heated for 3h at 160ºC in oil bath; then, the products were dried in a vacuum drying oven. 
 
Measurements of surrounding copper ions concentration in composite solutions of rGO and copper ions: The rGO 
suspension was directly added to CuSO4 solution to achieve the rGO–copper composite solution. The copper ions being 
adsorbed by rGO was investigated at a temperature of 293 K. The rGO suspensions were added with a volume ratio of 
1:1 into the CuSO4 solutions, respectively. The mixed solutions were shaken at 180 rpm for 1 hour in 293 K constant 
temperature bath. These rGO–copper composite solutions were vacuum filtered through a microfiltration filter with a 
pore size of 0.22 μm (GREEN MALL, China) to remove rGO. The concentration of copper ions was determined with 
PS7800 inductively coupled plasma optical emission spectrometer (ICP-OES, detection limits 0.01~200 ppm (mg L-1)). 
 
Cell strains: Escherichia coli (E. coli) DH5α was used in this work as Gram-negative bacteria model, and 
Staphylococcus aureus (S. aureus) CMCC, as Gram-positive bacteria model. Chlamydomonas reinhardtii CC-125 was 
from Guoliang Xu’s Lab (Shanghai Institute of Biochemistry and Cell Biology, CAS in China), used as algae model. 
Human Embryonic Kidney 293T (HEK293T) was used as mammalian cell model. 
 
Antibacterial activity enhancement test against E. coli and S. aureus by colony forming assays: Antibacterial activities of 
rGO solution, CuSO4 solution and rGO–copper composite solution were evaluated using E. coli and S. aureus. The 
bacteria cells were cultivated in Luria-Bertani (LB) medium (1% w/v tryptone, 0.5% w/v yeast extract, and 0.5% w/v 
NaCl) under shaking at 200 rpm at 37ºC for 16 hour (h) until it reached stationary growth phase. The bacteria cells were 
harvested by centrifugation at 4500 rpm for 5 min and washed two times with deionized water, and finally re-suspended 
in deionized water. Then, 500 µL of bacteria cells suspensions were introduced to 99.5 mL solutions, including deionized 
water (as a control), rGO solution (40 µg mL-1), CuSO4 solution (3 µM) or rGO–copper composite solution (rGO, 40 µg 
mL-1, and CuSO4, 100 µM), with a cell concentration of approximately 108 mL-1 (for E. coli) or 1010 mL-1 (for S. aureus) 
based on their optical densities (OD600nm). The 3 µM CuSO4 solution is postulated to be a reference of the surrounding 
copper ions in the rGO–copper composite solution. These samples were incubated at room temperature under continuous 
shaking at 200 rpm for 2 h for antibacterial testing. To quantify the number of viable bacteria cells, each sample was 
diluted with standard serial dilution (by 104 folds for E. coli and 106 folds for S. aureus), and 500 µL of the suspension 
from each sample was uniformly spread on the LB agar plates and the number of viable bacterial colonies was counted 
after incubation at 37ºC for 24 h. Three parallel experiments with bacterial cells incubated independently for 
antibacterial testing were performed for checking reproducibility, and in each parallel experiment, three samples were 
adopted to evaluate the average number of viable bacterial colonies and its standard deviations. The antibacterial activity 
is calculated as the ratio of the colony number in the control experiment divided by the colony numbers in antibacterial 
experiments. The enhancement ratio of antibacterial activity is calculated as the ratio of the rGO–copper antibacterial 
activity divided by the antibacterial activity of its surrounding copper ions. 
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Antibacterial activities of GOdot solution, CuSO4 solution and GOdot–copper composite solution were evaluated using 
E. coli and S. aureus. The above similar test procedures were carried out, with GOdot solution (40 µg mL-1), CuSO4 
solution (3 µM) or GOdot–copper composite solution (GOdot, 40 µg mL-1, and CuSO4, 100 µM), and with a cell 
concentration of approximately 108 mL-1 (for both E. coli and S. aureus). To quantify the number of viable bacteria cells, 
each sample was diluted with standard serial dilution by 106 folds, and 500 µL of the suspension from each sample was 
uniformly spread on the LB agar plates. 
 
Antibacterial activities of ZnSO4 and rGO–zinc composite as well as NiSO4 and rGO–nickel composite were evaluated 
using E. coli. The above similar test procedures were carried out with the rGO solution (40 µg mL-1), ZnSO4 or NiSO4 
solution (3 µM), and with a cell concentration of approximately 108 mL-1. Antibacterial activities of ZnSO4 and 
GOdot–nickel and the antibacterial activities of NiSO4 and GOdot–nickel were evaluated using E. coli. The above 
similar test procedures were carried out with the GOdot solution (40 µg mL-1), ZnSO4 or NiSO4 solution (3 µM), and 
with a cell concentration of approximately 108 mL-1. To quantify the number of viable bacteria cells, each sample was 
diluted with standard serial dilution by 106 folds, and 500 µL of the suspension from each sample was uniformly spread 
on the LB agar plates. 
 
Algaecide enhancement test against Chlamydomonas reinhardtii by fluorescein diacetate (FDA) assays: Algae 
(Chlamydomonas reinhardtii) cells ware incubated in TAP medium in a biochemical incubator at 25 ºC under 12 h 
dark/lit illumination condition for 3 days until it reached exponential growth phase. The algae cells were harvested by 
centrifugation at 3000 rpm for 5 min and washed two times with fresh TAP medium. The cells were re-suspended in TAP 
medium itself as control, in TAP medium with rGO (40 µg mL-1), CuSO4 (3 µM), rGO–copper composite (rGO, 40 µg 
mL-1, and CuSO4, 100 µM), with a cell concentration of approximately 106 mL-1 based on the optical density OD750nm. 
The 3 µM CuSO4 solution is postulated to be a reference of the surrounding copper ions in the rGO–copper composite 
solution. After 30 min incubation, the cells were washed twice with fresh TAP medium by centrifugations at 3000 rpm 
for 5 min and again suspended in TAP medium. Then, for cell staining, 1 mL of algae cell suspension was mixed with 1 
µL of FDA stock solution in acetone (2% w/v) and incubated for 5 min at room temperature. Finally, the cells were 
washed twice and re-suspended in 1 mL of TAP medium. The viable cells were identified by the green fluorescent 
fluorescein which cellular esterases in the viable cells metabolize FDA and release, since dead cells do not cleave FDA 
and are distinguished by red fluorescence emitted from chlorophyll. Thus, 20 µL of cells suspension from each sample 
was uniformly spread on siliconized glass cover slide (FAstal BioTech). We used an inverted confocal microscope 
system equipped with a 60x immersion oil objective (Olympus PlanApo 60x; Cargille Type DF ImmersionOil) and CCD 
camera (sCOMS, 1270*1030 pixels, quantum yield=0.76, Dayueweijia (Beijing) Technology Co.,Ltd) equipped with 
Semrock 570/70 bandpass filter to take fluorescence pictures for counting the number of viable cells. The green 
fluorescence was emitted when excited at 488 nm laser with 30 μW intensity. 30 parallel experiments with algae cells 
incubated independently for algaecide testing were performed to evaluate the average number of viable cells and its 
standard deviations. The algaecide activity is calculated as the ratio of the viable cells number in the control experiment 
divided by the viable cells numbers in algaecide experiments. The enhancement ratio of algaecide activity is calculated 
as the ratio of the rGO–copper algaecide activity divided by the algaecide activity of its surrounding copper ions. 
 
Cytotoxicity test to HEK 293T cells by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromid (MTT) assay: 
HEK293T cells were grown at 37ºC with 5% CO2 in dimethyl sulfoxide (DMEM, Dulbecco's modified eagle medium, 
Sigma, Poole, UK) for 2 days to their logarithmic phase. The cells were harvested by centrifugation at 5000 rpm for 5 
min and adjusted the cell concentration to 104~105 mL-1 (counted with hemocytometers). Then 100 µL cells were added 
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into every well of the 96-well plates and incubated for 2 h until all the cells adhered to the wall, and then the supernatant 
was removed and replaced by fresh DMED mediums itself as control, or by DMED mediums with rGO (40 µg mL-1), 
CuSO4 (3 µM) or rGO–copper composite (rGO,40 µg mL-1, and CuSO4, 100 µM). After 4 h, the supernatant was 
removed and replaced by 100 µL of PBS, and then, 20 µL of MTT (5 mg mL-1 in DMEM) was added into each well and 
the cells were incubated at 37ºC for another 4 h to form formazan. Finally, the supernatant with MTT was removed again, 
and 150 µL of DMSO was added to each well and the cells were incubated for 30 min to dissolve the formazan. The 
optical density (OD) at 490 nm were monitored by Synergy™ 2 Multi-Mode Microplate Reader (BioTek), and the 
cytotoxicity is calculated as the ratio of the OD490nm in the control experiment divided by the OD490nm in cytotoxicity 
experiments. The enhancement ratio of cytotoxicity is calculated as the ratio of the cytotoxicity of the rGO–copper 
composite divided by the cytotoxicity of its surrounding copper ions. Three parallel experiments with HEK 293T cells 
incubated independently for cytotoxicity testing were preformed to evaluate the average OD490nm and its standard 
deviations. 
 
Scanning Electron Microscopy (SEM) and Energy Dispersive Spectrometer (EDS) mapping images: The E.coli cells 
(~104 mL-1) were suspended specifically in deionized water, rGO solution (40 µg mL-1), CuSO4 solution (3 µM) or 
rGO–copper composite solution (rGO, 40 µg mL-1, and CuSO4, 100 µM) and then cultured at room temperature for 30 
min. 100 µL of cells was dropped on the glass slide and dried by infrared heat lamp. The cells were sputter coated with 
platinum (20s, 20 mA) and then imaged with an SEM (LEO 1530vp) under 15 kV energy level radiation to analyze the 
morphology and EDS profile of cells. The element carbon and copper contents were quantified with the intensity of the 
peak at 0.27 keV and 0.93 keV respectively. 
 
Computer simulation methods: In the DFT calculations, the structures of rGO with copper ion being adsorbed 
(rGO–copper) and the structure of rGO were optimized at the B3LYP/6-31+G(d,p) level of theory. [16] The geometry 
optimizations were performed via the Berny algorithm [29] with the convergence criteria of a maximum step size is 
0.0018 au. and a root mean square (RMS) force is 0.0003 au. The visualized molecular orbitals were derived from the 
Kohn–Sham formalism and shown as an iso-surface value of 0.005 a.u. These calculations were carried out with the 
Gaussian 09 software package. [30] The binding energy of the copper ion adsorbed onto rGO is calculated by a formula of 
∆E = ErGO–copper – Ecopper – ErGO, where ErGO–copper, Ecopper and ErGO are the total energies of optimized rGO–copper 
composite, copper ion and rGO, respectively. 
 
We performed MD simulations for both rGO and rGO–copper composite interacting with E. coli membranes. The 
simulation systems and a configuration of rGO-copper composite were shown in Figure S6 in Supporting Information. 
The rGO sheet (3.92 nm × 2.84 nm) were constructed based on the Shi-Tu structure model. [8a, 10a] The detailed 
parameters of rGO force field can be referred to previous publications. [10a, 18, 31] 10 sites on the rGO sheet were randomly 
selected to constrain 10 copper ions to model rGO–copper composite based on their cation–π interactions (Supporting 
Information, Figure S5). At each selected site, copper ion was constrained to its nearest carbon atom by a harmonic 
potential with the spring constant of 50 kcal mol-1 Å-2, approximately at the same order magnitude of the adsorption 
energies (Supporting Information, Figure S5). The negatively charged cell membrane that usually occurs in bacterial 
cells (for example, E. coli [19]) was modelled by a mixture of neutral POPE and negatively charged POPG at a 3:1 ratio. 
[32] In MD simulations, the GROMOS lipid force field (Berger) for POPE and POPG was adopted, which has been 
validated extensively. [33] Water molecules were represented by the simple point-charge SPC/E model. The periodic 
boundary conditions were applied in all directions. MD simulations were performed with Gromacs 4.5.7 software 
Package. The NPT ensemble is used with a time step of 2 fs, the temperature is maintained at 310 K by a Berendsen 
thermostat with a coupling coefficient of τT = 0.1 ps, and the pressure is kept at 1 bar by the Berendsen barostat with a 
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coupling coefficient of τP = 1 ps. The particle-mesh Ewald method was adopted for the long-range electrostatic 
interactions with a cutoff of 1.2 nm, whereas a cutoff of 1.2 nm was also applied to the van der Waals interactions. The 
solvated lipid systems were initially equilibrated for 40ns. Then, the rGO sheet or rGO-copper composite was introduced 
into the system by replacing overlapping water molecules, and position restraints were applied to the rGO sheet and 
rGO-copper composite for 20 ns to allow systems re-equilibration. After the equilibration processes, the position 
restraints on the rGO sheet or rGO-copper composite were released and the consequent systems were adopted to 
continue to run MD simulations for analyzing both rGO sheet and rGO-copper composite interacting with the 
membranes. 
 
Supporting Information 
Supporting Information is available from the Wiley Online Library or from the author. 
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